NBC Securities’s Grace Therapeutics GRCE Stock Holding History

NBC Securities’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	2	–	–	﹤0.01%	2416
2026 Q1	$9	Hold	2	–	–	﹤0.01%	2535
2025 Q4	$6	Hold	2	–	–	﹤0.01%	2777
2025 Q3	$5	Buy	+2	New	+$6	﹤0.01%	2766
2024 Q2	–	Sell	-2	Closed	-$1K	–	2224
2024 Q1	$1K	Buy	+2	New	+$6	﹤0.01%	2158
2023 Q4	–	Sell	-2	Closed	–	–	2244
2023 Q3	$0	Buy	+2	New	+$5	﹤0.01%	2184

Other funds holding GRCE

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

NBC Securities's GRCE Position: Q2 2026 in Review

NBC Securities held its Grace Therapeutics (GRCE) position steady in Q2 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

NBC Securities first reported a position in GRCE in Q3 2023 and has held it in 6 quarters since. The position peaked at $1K in Q1 2024. 2 funds tracked by Wall St. Rank hold GRCE as of Q2 2026.

NBC Securities held 2 shares of Grace Therapeutics worth $4 as of Q2 2026.
NBC Securities left its Grace Therapeutics share count unchanged in Q2 2026.
Grace Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2416 holding.
NBC Securities first reported a position in Grace Therapeutics in Q3 2023 and has held it in 6 quarters since.
NBC Securities's Grace Therapeutics position peaked at $1K in Q1 2024.
2 funds tracked by Wall St. Rank held Grace Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.